Compare, Analyse TTK HEALTHCARE with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TTK HEALTHCARE   MYLAN
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
MYLAN
Dec-18
TTK HEALTHCARE/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,2153,503-   
Low Rs6101,928-   
Sales per share (Unadj.) Rs444.41,611.8-  
Earnings per share (Unadj.) Rs17.243.8-  
Cash flow per share (Unadj.) Rs27.6345.6-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs177.91,743.7-  
Shares outstanding (eoy) m14.13514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.11.7 121.9%   
Avg P/E ratio x52.962.0 85.3%  
P/CF ratio (eoy) x33.07.9 420.3%  
Price / Book Value ratio x5.11.6 329.3%  
Dividend payout %29.00-   
Avg Mkt Cap Rs m12,8941,397,110 0.9%   
No. of employees `0002.335.0 6.6%   
Total wages/salary Rs m1,3070-   
Avg. sales/employee Rs Th2,715.723,693.9 11.5%   
Avg. wages/employee Rs Th565.30-   
Avg. net profit/employee Rs Th105.4643.4 16.4%   
INCOME DATA
Net Sales Rs m6,279829,286 0.8%  
Other income Rs m780-   
Total revenues Rs m6,356829,286 0.8%   
Gross profit Rs m496214,588 0.2%  
Depreciation Rs m147155,275 0.1%   
Interest Rs m3439,886 0.1%   
Profit before tax Rs m39319,428 2.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m149-3,091 -4.8%   
Profit after tax Rs m24422,519 1.1%  
Gross profit margin %7.925.9 30.5%  
Effective tax rate %37.9-15.9 -238.4%   
Net profit margin %3.92.7 142.9%  
BALANCE SHEET DATA
Current assets Rs m2,717463,072 0.6%   
Current liabilities Rs m1,571337,631 0.5%   
Net working cap to sales %18.315.1 120.7%  
Current ratio x1.71.4 126.1%  
Inventory Days Days3284 38.5%  
Debtors Days Days4793 50.0%  
Net fixed assets Rs m991160,868 0.6%   
Share capital Rs m141442 32.0%   
"Free" reserves Rs m2,3730-   
Net worth Rs m2,514897,136 0.3%   
Long term debt Rs m3968,297 0.0%   
Total assets Rs m4,1582,406,467 0.2%  
Interest coverage x12.61.5 848.3%   
Debt to equity ratio x01.1 0.1%  
Sales to assets ratio x1.50.3 438.2%   
Return on assets %6.72.6 257.4%  
Return on equity %9.72.5 386.2%  
Return on capital %16.93.2 532.6%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Net fx Rs m1540-   
CASH FLOW
From Operations Rs m173172,326 0.1%  
From Investments Rs m97-89,073 -0.1%  
From Financial Activity Rs m-307-80,279 0.4%  
Net Cashflow Rs m-381,428 -2.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.59 Rs / USD

Compare TTK HEALTHCARE With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare TTK HEALTHCARE With: FRESENIUS KABI ONCO.  DR. DATSONS LABS  SUVEN LIFE SCIENCES  AUROBINDO PHARMA  FULFORD INDIA  



Today's Market

TRAI Data for February, Siemens March Quarter Performance, and Buzzing Stocks Today(Pre-Open)

Indian share markets witnessed selling pressure on Wednesday and ended lower.

Related Views On News

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

More Views on News

Most Popular

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

The Worst Sector in the Market (Fast Profits Daily)

May 11, 2021

The worst sector in the stock market according to the charts.

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

TTK HEALTHCARE SHARE PRICE


May 12, 2021 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - STERLING BIOTECH COMPARISON

COMPARE TTK HEALTHCARE WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS